UK MDR 2002 Post-Market Surveillance as we move into 2026
As the transition to the UK Medical Device Regulations 2002 continues, Post-Market Surveillance (PMS) has become a core requirement for maintaining device conformity. The current regulatory environment expects manufacturers to demonstrate ongoing performance and safety using real-world data, with PMS operating as a living part of the quality system rather than an archived document.
For many organisations balancing MDR, UKCA and day-to-day operations, PMS is an area that can lag behind simply because other activities appear more urgent. Data is often available, but the challenge lies in how it is assessed, trended, documented and linked back into technical files and lifecycle evidence.
Where PMS frameworks commonly require attention
When reviewing PMS arrangements for manufacturers, similar themes frequently appear:
- PMS plans created historically but not updated for the UK MDR
- Data collected, but evaluation or trending not recorded clearly
- PMS output not consistently linked back into risk or clinical evidence
- Reporting performed when needed rather than on a defined schedule
- Evidence held in multiple places rather than consolidated for review
These are operational challenges and can lead to additional workload later during audits, renewals or technical documentation updates. Strengthening PMS early is usually more efficient than remediation later.
What PMS must demonstrate under the UK MDR
A compliant PMS system should:
- monitor real-world performance and safety
- support proactive review, not solely reactive reporting
- inform risk management and clinical evaluation
- provide structured PMS reports at planned intervals
- justify the level of surveillance undertaken
- maintain traceability across lifecycle documentation
In practice, PMS should support the evidence narrative of the device throughout its life on the market.
A practical route forward for manufacturers
PMS improvement does not need to be disruptive, but it does need to be purposeful and clearly documented. Manufacturers often benefit from support with:
- reviewing PMS arrangements against UK MDR
- defining proportionate review and reporting frequency
- improving documentation structure for clarity and traceability
- ensuring PMS feeds effectively into CER, PMCF and risk files
- preparing documentation that stands up to regulatory scrutiny
The most effective approach depends on device classification, available data and the maturity of the existing QMS. Tailored support is usually more efficient than generic templates.
Cost-effective PMS support for manufacturers
QAEC Limited works with organisations seeking practical PMS improvement without unnecessary complexity or cost. We support manufacturers with:
- PMS plan updates aligned to UK MDR
- PMS reporting and documentation structure
- Complaint trending and evaluation approaches
- Integration of PMS outputs into lifecycle evidence
- Practical guidance based on real-world implementation
Support is available as a focused one-off review or ongoing assistance, depending on your requirements.
